Aytu Biopharma, Inc. (AYTU)
2.56
-0.01
(-0.39%)
USD |
NASDAQ |
May 06, 16:00
2.56
0.00 (0.00%)
After-Hours: 20:00
Aytu Biopharma Profit Margin (Quarterly) : -69.79% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Illumina, Inc. | 12.28% |
| ACADIA Pharmaceuticals, Inc. | 96.33% |
| Agenus, Inc. | -31.03% |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -100.7% |
| Return on Assets | -20.07% |
| Return on Invested Capital | -52.23% |
| Gross Profit Margin (Quarterly) | 59.99% |
| Operating Margin (Quarterly) | -12.99% |
| Return on Net Operating Assets | -25.92% |